Scheupbach et al., "Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS," Science, 224, 503-505 (1984). |
Kalyanaraman et al., "Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS," Science, 225, 321-323 (1984). |
Robey et al., "Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients," Science, 228, 593-595 (1985). |
Allan et al., "Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-III," Science, 228, 1091-1094 (1985). |
Crowl et al., "HTLV-III Env Gene Products Synthesized in E. coli are Recognized By Antibodies Present in the Sera of AIDS Patients," Chemical Abstracts, 103, p. 190, No. 154983e (1985). |
Montagnier et al., "Identification and Antigenicity of the Major Envelope Glycoprotein of Lymphadenopathy-Associated Virus," Chemical Abstracts, 103, p. 263, No. 34641v (1985). |
Weiss et al., "Neutralization of Human T-Lymphotropic Virus Type III by Sera of AIDS and AIDS-Risk Patients," Nature, 316, 69-72 (1985). |
Barin et al., "Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS Patients," Science, 228, 1094-1096 (1985). |
Wain-Hobson et al., "Nucleotide Sequence of the AIDS Virus, LAV," Cell, 40, 9-17 (1985). |
Muesing et al., "Nucleic Acid Structure and Expression of the Human AIDS/Lymphadenopathy Retrovirus," Nature, 313, 450-458 (1985). |
Schneider et al., "A Glycopolypeptide (gp 100) is the Main Antigen Detected by HTLV-III Antiserums,"Chemical Abstracts, 103, p. 430, No. 52370k (1985). |
Sarngadharan et al., "Immunological Properties of HTLV-III Antigens Recognized By Sera of Paatients with AIDS-Related Complex and of Asymptomatic Carriers of HTLV-III Infection," Chemical Abstracts, 103, p. 551, No. 121329t (1985). |
Alizon et al., "Molecular Cloning of Lymphadenopathy-Associated Virus," Nature, 312, 757-760 (1984). |
Chang et al., "An HTLV-III Peptide Produced by Recombinant DNA is Immunoreactive With Sera From Patients With AIDS," Nature, 315, 151-154 (1985). |
Chang et al., "Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a Recombinant Escherichia coli-Derived Viral Antigenic Peptide," Biotechnology, 3, 905-909 (1985). |
Ratner et al., "Complete Nucleotide Sequence of the AIDS Virus, HTLV-III,"Nature, 313, 277-284 (1985). |
Dreesman et al., "Antibody to Hepatitus B Surface Antigen After a Single Inoculation of Uncoupled Synthetic HBsAg Peptides," Nature, 295, 158-160 (1982). |
Kitchen et al., "Aetiology of AIDS-Antibodies to Human T-Cell Leukaemia Virus (Type III) in Haemophiliacs,"Nature, 312, 367-369 (1984). |
Essex et al., "Antibodies to Cell Membrane Antigens Associated with Human T-Cell Leukemia Virus in Patients with AIDS," Science, 220, 859-862 (1983). |
Seiki et al., "Human Adult T-Cell Leukemia Virus: Complete Nucleotide Sequence of the Provirus Genome Integrated in Leukemia Cell DNA," Proc. Natl. Acad. Sci., USA, 80, 3618-3622 (1983). |
"Centocor Unveils R-DNA AIDS Assay; Faces FDA," Biotechnol. Newswatch, vol. 5, p. 3, Abstract No. 03-10-003226 (1985). |
Arya et al., "Homology of Genome of AIDS-Associated Virus With Genomes of Human T-Cell Leukemia Viruses," Science, 225, 927-930 (1984). |
Kamlehar, S. et al. Science 262:1680-1685 (1993). |
Guy, B. et al. Nature 330:266-269 (1987). |